Literature DB >> 6235992

Bone marrow transplantation in man. Analysis of T and B cell functions in PWM driven Ig production.

H C Rümke, F G Terpstra, M T Roos, J M Vossen, L J Dooren, P T Schellekens, W P Zeijlemaker.   

Abstract

The functional activity of B and T lymphocytes from the blood of eight patients, who had successfully been treated with allogeneic bone marrow for severe aplastic anaemia or acute leukaemia, was studied in pokeweed mitogen (PWM) driven polyclonal immunoglobulin synthesis. Activity of B cells was measured as IgM and IgG synthesis by a standard number (40 X 10(3] of patient lymphocytes in the presence or absence of healthy donor T cells. In addition, the frequency of PWM reactive B cells, giving rise to IgM and/or IgG producing daughter cells, was estimated by limiting dilution analysis. With this method, it was found that only a small percentage (1-3%) of peripheral blood B cells from healthy individuals is reactive to PWM. In the patients, both parameters for B cell reactivity were decreased during the first 40 weeks after bone marrow transplantation. As parameters for T cell activity, help and suppression on the Ig production by healthy donor lymphocytes were tested. In most patients, T helper cell activity was strongly decreased, whereas some patients had excessive T suppressor cell activity. The observed functional activities were only partially correlated with the marker profile of the T cell populations, as detected by reactivity with monoclonal antibodies. Each patient had a distinct, individual pattern of reconstitution of these functions. There was no positive correlation between Ig production in vitro and the capacity to form antibodies in vivo, nor between the other in vitro findings and clinical features, such as the occurrence of infections or graft versus host disease.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6235992      PMCID: PMC1536117     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  36 in total

1.  Immunodeficiency following allogeneic bone marrow transplantation.

Authors:  R P Gale; G Opelz; M R Mickey; P R Graze; A Saxon
Journal:  Transplant Proc       Date:  1978-03       Impact factor: 1.066

2.  The mixed lymphocyte reaction (MLR) stimulatory capacity of human lymphocyte subpopulations.

Authors:  M H van Oers; W P Zeijlemaker
Journal:  Cell Immunol       Date:  1977-06-15       Impact factor: 4.868

3.  Does graft-versus-host disease influence the tempo of immunologic recovery after allogeneic human marrow transplantation? An observation on 56 long-term survivors.

Authors:  D R Noel; R P Witherspoon; R Storb; K Atkinson; K Doney; E M Mickelson; H D Ochs; R P Warren; P L Weiden; E D Thomas
Journal:  Blood       Date:  1978-06       Impact factor: 22.113

4.  Immunodeficiency following human marrow transplantation: in vitro studies.

Authors:  J E Neely; A N Neely; J H Kersey
Journal:  Transplant Proc       Date:  1978-03       Impact factor: 1.066

5.  Effect of prior blood transfusions on marrow grafts: abrogation of sensitization by procarbazine and antithymocyte serum.

Authors:  R Storb; G L Floersheim; P L Weiden; T C Graham; H J Kolb; K G Lerner; M L Schroeder; E D Thomas
Journal:  J Immunol       Date:  1974-04       Impact factor: 5.422

6.  Enhancement by irradiated T cells of human plasma cell production: dissection of helper and suppressor functions in vitro.

Authors:  F P Siegal; M Siegal
Journal:  J Immunol       Date:  1977-02       Impact factor: 5.422

7.  Aberrations of suppressor T cells in human graft-versus-host disease.

Authors:  E L Reinherz; R Parkman; J Rappeport; F S Rosen; S F Schlossman
Journal:  N Engl J Med       Date:  1979-05-10       Impact factor: 91.245

8.  Localized scleroderma-like lesions after bone marrow transplantation in man. A chronic graft versus host reaction.

Authors:  W A Van Vloten; E Scheffer; L J Dooren
Journal:  Br J Dermatol       Date:  1977-04       Impact factor: 9.302

9.  Aplastic anemia treated by allogeneic bone marrow transplantation: a report on 49 new cases from Seattle.

Authors:  R Storb; E D Thomas; P L Weiden; C D Buckner; R A Clift; A Fefer; L P Fernando; E R Giblett; B W Goodell; F L Johnson; K G Lerner; P E Neiman; J E Sanders
Journal:  Blood       Date:  1976-12       Impact factor: 22.113

10.  T-cell subpopulations identified by monoclonal antibodies after human marrow transplantation. I. Helper-inducer and cytotoxic-suppressor subsets.

Authors:  K Atkinson; J A Hansen; R Storb; S Goehle; G Goldstein; E D Thomas
Journal:  Blood       Date:  1982-06       Impact factor: 22.113

View more
  1 in total

1.  Rapid recovery of helper activity following T cell depleted allogeneic marrow transplant.

Authors:  J Z Wimperis; M K Brenner; H G Drexler; A V Hoffbrand; H G Prentice
Journal:  Clin Exp Immunol       Date:  1987-09       Impact factor: 4.330

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.